News from huya bioscience international A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 28, 2020, 08:05 ET HUYA Bioscience International Announces Orphan Drug Designation for HBI-8000 Monotherapy Adult T-cell Leukemia-Lymphoma ATL in Japan

HUYA Bioscience International (HUYABIOTM), the leader in accelerating global development of China's pharmaceutical innovations, announced today the...


Aug 04, 2020, 08:05 ET HUYA Bioscience International Licenses the Novel SHP2 Inhibitor HBI-2376 for Development in Oncology

HUYA Bioscience International (HUYABIO ® ), the leader in accelerating global development of China's pharmaceutical innovations, announced today it...


Feb 28, 2020, 08:05 ET HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000

HUYA Bioscience International, the leader in accelerating global development of China's pharmaceutical innovations, has presented the results of a...


Jan 08, 2020, 08:05 ET HUYA Bioscience International Appoints Meiji Seika Pharma as Exclusive Distributor For HBI-8000 in Japan and Other Asian Countries

HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointment of Meiji Seika Pharma (Meiji) as an exclusive...


Jun 04, 2018, 08:00 ET HUYA Bioscience International expanded oncology pipeline includes combination with checkpoint inhibitor for solid tumors

HUYA Bioscience International (HUYA), the leader in accelerating global development of China's pharmaceutical innovations, today announced it is at a ...


Jul 10, 2017, 08:05 ET HUYA Bioscience International Establishes Strategic Partnership with Suzhou BioTOP

HUYA Bioscience International, the leader in accelerating global development of China's pharmaceutical innovations, today announced a strategic...


Jan 18, 2017, 07:05 ET HUYA Bioscience International and CAS Innovation and Investment Company Establish Strategic Collaboration

HUYA Bioscience International, (HUYA), the leader in accelerating the global development of China's pharmaceutical innovations, announced today a...


Dec 14, 2016, 08:05 ET HUYA Bioscience International Sponsors 12th Annual Scrip Awards 'Best New Drug' Category

For the second straight year, HUYA Bioscience International (HUYA) was a proud sponsor of the 'Best New Drug' category at the Annual Scrip Awards. Dr....


Mar 24, 2016, 08:05 ET HUYA Bioscience International's Dr. Mireille Gillings Named Pharma Executive of the Year at the BioPharma Industry Awards 2016

HUYA Bioscience International (HUYA) Founder and Executive Chair Mireille Gillings, Ph.D., has been named Pharma Executive of the Year at the...


Mar 22, 2016, 08:09 ET HUYA Bioscience International Celebrates 10 Years in China

HUYA Bioscience International (HUYA) celebrated the 10th anniversary of the opening of its first offices in China with a gala dinner at the 'M on the ...


Mar 15, 2016, 12:00 ET HUYA Bioscience International Acquires Exclusive Rights to Immuno-Oncology Products from Fudan University

HUYA Bioscience International (HUYA), the leader in accelerating global development of China's pharmaceutical innovations, today announced it has...


Mar 03, 2016, 08:05 ET Huya Bioscience International Expands Senior Management Team

HUYA Bioscience International (HUYA) today announced the appointment of Akira Miyazato, MD, Ph.D. as VP, Head of Clinical Research and Development in ...


Feb 01, 2016, 03:30 ET HUYA Bioscience International Grants An Exclusive License For HBI-8000 In Japan And Other Asian Countries To Eisai

HUYA Bioscience International (HUYA) President, CEO, Executive Chairman & Founder Dr. Mireille Gillings announced that Eisai Co., Ltd. has acquired...


Dec 23, 2015, 08:35 ET HUYA Bioscience International Adds To Senior Management Team

HUYA Bioscience International (HUYA) today announced the addition of Andy Claude, C.P.A. as Vice President, Finance. His addition to the senior...


Dec 22, 2015, 08:35 ET Huya Bioscience International Announces Orphan Drug Designation For HBI-8000 In Japan

HUYA Bioscience International (HUYA), Founder, CEO & Executive Chair, Dr. Mireille Gillings today announced that the Ministry of Health, Labour and...


Dec 15, 2015, 08:35 ET HUYA Bioscience International Expands Senior Management Team

HUYA Bioscience International (HUYA) today announced the appointment of Scott Garrett, M.B.A. as Vice President, Commercial Planning. His addition to ...


Dec 10, 2015, 08:35 ET HUYA Bioscience International Expands Senior Management Team

HUYA Bioscience International (HUYA) today announced the appointment of Dmitri Kharkevitch, M.D., Ph.D., as Vice President, Clinical Development...


Dec 03, 2015, 08:35 ET HUYA Bioscience International Sponsors 'Best New Drug' Category at SCRIP Awards

HUYA Bioscience International (HUYA) was a proud sponsor of the 'Best New Drug' category at the 11th Annual SCRIP Awards. Dr. Mireille Gillings was a ...


Dec 02, 2015, 08:35 ET HUYA Bioscience International Expands into South Korea

HUYA Bioscience International (HUYA), the global leader in accelerating drug discovery and development of biopharma innovation originating in China,...


Nov 30, 2015, 08:35 ET HUYA Bioscience International Announces A Strategic Alliance With The Korea Drug Development Fund

HUYA Bioscience International, the leader in accelerating global development of China's pharmaceutical innovations, today announced it has signed a...


Nov 16, 2015, 09:05 ET HUYA Bioscience International Celebrates its 10th Anniversary

HUYA Bioscience International (HUYA) just celebrated its 10th anniversary of the company's founding with a black tie gala event on November 13 at the ...


Nov 09, 2015, 09:05 ET HUYA Bioscience International and TechCode Gu'an Life Sciences Park Establish Strategic Collaboration

HUYA Bioscience International, the leader in accelerating the global development of China's pharmaceutical innovations, today announced a strategic...


Oct 08, 2015, 08:05 ET HUYA Bioscience International Strengthens Business Development in China

HUYA Bioscience International (HUYA) today announced an expansion of its Senior Management Team, with the appointment of Shawn Xiaojun Mu, Ph.D., as...


Sep 16, 2015, 08:35 ET HUYA Bioscience International Further Expands Executive Team

HUYA Bioscience International (HUYA) today announced the expansion of its Executive Team with the appointment of Gloria Tsi-Yie Lee, M.D., Ph.D., as...


Sep 03, 2015, 08:35 ET HUYA Bioscience International Announces Epigenetic Breast Cancer Program

HUYA Bioscience International (HUYA) today announced expanding clinical trials with its lead cancer drug, HBI-8000, starting with a Phase 1...